gms | German Medical Science

27. Deutscher Krebskongress

Deutsche Krebsgesellschaft e. V.

22. - 26.03.2006, Berlin

Ultraradical resection of thyroid carcinoma: surgical heroism or multilation?

Meeting Abstract

Suche in Medline nach

  • corresponding author presenting/speaker Markus Dürsch - Universitätsklinikum, Erlangen, Deutschland
  • B. Reingruber - Universitätsklinikum, Erlangen
  • W. Hohenberger - Universitätsklinikum, Erlangen

27. Deutscher Krebskongress. Berlin, 22.-26.03.2006. Düsseldorf, Köln: German Medical Science; 2006. DocPO253

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/dkk2006/06dkk363.shtml

Veröffentlicht: 20. März 2006

© 2006 Dürsch et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielf&aauml;ltigt, verbreitet und &oauml;ffentlich zug&aauml;nglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

In medullary thyroid carcinoma, surgery is the only validated therapeutic option. We report the case of a 12 year old girl with a metastatic and locally advanced medullary thyroid carcinoma. At the time of presentation, the patient had severe obstructive respiratory failure due to a thyroid tumor which had grossly infiltrated a long tracheal segment, both recurrent nerves and the esophagus. Furthermore, large bilateral cervical lymph node metastases reached up to the base of the skull. In July 2004 we performed a multivisceral resection of the thyroid including a 4cm segment of the trachea, the recurrent nerves, the anterior esophageal wall and an extended radical bilateral neck dissection. Additionally, a tracheostomy and a gastrostomy had to be created. Macroscopically, the tumor could cmpletely resected. Histopathological staging revealed a medullary thyroid carcinoma UICC IV (pT4, pN1 (56/82), L1, V0, M0, R1). The girl was included in an experimental study protool of a combined high dose radio-chemotherapy. She has been followed up in 3 monthly intervals and has no evidence of residual disease or recurrence today, 18 months after surgery. With view to her permanent functional impairments we will discuss whether this ultra-radical surgical approach is justifiable.